Loading...
Monsanto Company signs share subscription agreement with Devgen
17-Sep-2007
Advertisement
Devgen and Monsanto Company announced that they have signed an agreement in which Monsanto has agreed, subject to certain customary conditions, to subscribe to 1,045,400 Devgen shares at 17.22EUR/share, totaling 18 million EUR (25 million $) and representing 5.9% of the outstanding capital of Devgen NV. Closing is expected to take place no later than November 2007.
It is anticipated, that Monsanto's becoming a shareholder of Devgen will complement the ongoing collaboration and technology exchange agreements of the companies.
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
Nuevolution Announces Worldwide Technology Cross-Licensing Agreement with GSK
Wuxi Rich Intelligent Equipment Co., Ltd. - Wuxi, China
How many people actually have Covid-19? - According to a study, the number of undetected cases of infected persons differs significantly in different countries
Valeant Pharmaceuticals Acquires Probiotica in Brazil
Alligator Bioscience AB appoints Sibylle Lenz as Chief Executive Officer
Quotient Bioresearch's New Radiochemistry Facility Fully Operational
Ancient rocks record first evidence for photosynthesis that made oxygen
Novel protein to prevent immune system attacks on own body - 1.2 million euros for immunology start-up
TB Alliance and BioFocus sign compound management agreement
Xceleron and Covance enter co-promotional agreement
Researchers snap giant virus in 3-D - Study demonstrates potential of future X-ray laser investigations
